NPY/Y1 receptor‐mediated vasoconstrictory and proliferative effects in pulmonary hypertension
Open Access
- 30 April 2014
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 171 (16) , 3895-3907
Abstract
Background and Purpose: Pulmonary arteries (PAs) are innervated, but little is known about the role of neuronal axis in pulmonary hypertension (PH). Here, we have examined the role of the neuropeptide Y (NPY) and its Y1 receptor in PH pathogenesis.Experimental Approach: NPY was localized by immunofluorescence. Expression of NPY and Y1 receptor were determined by quantitative PCR. Cellular response to NPY stimulation was assessed by Western blotting, thymidine incorporation and calcium imaging. Wire myography and isolated perfused mouse lung were applied to study pulmonary vasoactive effects of NPY. Selective receptor antagonists were used to assess the contribution of receptor subtypes in mediating NPY effects.Key Results: Samples from PH patients showed increased NPYergic innervation within the PA wall and higher Y1 receptor expression, compared with donors. However, NPY levels were unchanged in both PA and serum. In the chronic hypoxic mouse model, Y1 receptor were up‐regulated, while expression of both NPY and Y1 receptor was increased in the lungs of monocrotaline and SU5416‐hypoxia rats. On a functional level, NPY acutely increased intracellular calcium levels and enhanced vasoconstriction of lung vessels preconstricted with adrenaline. Furthermore, NPY stimulated proliferation of human pulmonary arterial smooth muscle cells and activated p38 and PKD pathways. Correspondingly, higher phosphorylation of PKD was observed in remodelled vessels from PH patients. The selective Y1 receptor antagonist, BIBO 3304, concentration‐dependently inhibited vasoconstrictive and proliferative effects of NPY.Conclusions and Implications: NPY and Y1 receptor are possible mediators of both vasoconstriction and pulmonary vascular remodelling in PH.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft
- Excellence Cluster Cardio-Pulmonary System
This publication has 47 references indexed in Scilit:
- Pulmonary Artery Denervation to Treat Pulmonary Arterial HypertensionJACC, 2013
- Double-Stranded RNA Attenuates the Barrier Function of Human Pulmonary Artery Endothelial CellsPLOS ONE, 2013
- The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in RatsPLOS ONE, 2012
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Cellular and Molecular Basis of Pulmonary Arterial HypertensionJACC, 2009
- Sympathetic neurogenic Ca2+ signalling in rat arteries: ATP, noradrenaline and neuropeptide YExperimental Physiology, 2008
- Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growthCanadian Journal of Physiology and Pharmacology, 2008
- Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cellsCanadian Journal of Physiology and Pharmacology, 2000
- Neuropeptide Y receptor-effector coupling mechanisms in cultured vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1988